A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

Clinical trial NCT03858634 · COMPLETED

Trial details

NCT number: NCT03858634
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Idiopathic Urticaria Chronic Idiopathic Pruritus Lichen Planus Lichen Simplex Chronicus Plaque Psoriasis

Start date: 2019-05-29
Primary completion: 2020-04-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.